glp 1/gip agonist Frontiers Science Behind GLP 1 GIP
Description
The results of a trial of semaglutide in obese patients with HFpEF showed a significant amelioration of symptoms and improvements in motor function and weight loss compared with patients treated with a placebo

If they wish, RxSS can facilitate approval from their prescriber

Current clinical trials have focused exclusively on adults, and there is a lack of data regarding its use in children and adolescents
Rieusset J

patients describe a quietening of what many in the clinical community now refer to as food noise, the persistent neurological signal that drives overconsumption independent of genuine caloric need

Back Dupr, J (26 Sept 1964) 'An intestinal hormone affecting glucose disposal in man', The Lancet , 672-73
